Proteins linked to atherosclerosis and cell proliferation are associated with the shrunken pore syndrome in heart failure patients
Open Access
- 7 March 2021
- journal article
- research article
- Published by Wiley in Proteomics – Clinical Applications
- Vol. 15 (4) , 2000089
Abstract
Purpose: The “Shrunken pore syndrome” (SPS) is characterized by a difference in renal filtration between cystatin C and creatinine, resulting in a low eGFRcystatinC/eGFRcreatinine‐ratio. Studies have demonstrated a high risk for cardiovascular morbidity and mortality for patients with SPS. In this discovery study, we explored associations between SPS and proteins implicated in cardiovascular disease and inflammation in patients with heart failure.Experimental Design: Plasma samples from 300 individuals in HARVEST‐Malmö trial hospitalized for the diagnosis of heart failure (mean age 74.9 ± 11.5 years; 30.0% female), were analyzed with a proximity extension assay consisting of 92 proteins. A Bonferroni‐corrected p‐value of 0.05/92 = 5.4 × 10−4 was considered significant in the initial age and sex‐adjusted analyses. Presence of SPS was defined as eGFRcystatinC ≤ 60% of eGFRcreatinine.Results: SPS presented with significant associations (p < 5.4 × 10−4) in age and sex‐adjusted logistic regressions with elevated levels of six proteins; scavenger receptor cysteine rich type 1 protein M130, tumor necrosis factor receptor 1, tumor necrosis factor receptor 2, osteoprotegerin, interleukin‐2 receptor subunit alpha, and tyrosine‐protein kinase receptor UFO. All proteins remained associated (p < 0.05) with SPS after multivariate adjustments.Conclusions and clinical relevance: In heart failure patients, SPS was associated with proteins linked to atherosclerosis and cell proliferation.Keywords
This publication has 41 references indexed in Scilit:
- Shrunken pore syndrome - a common kidney disorder with high mortality. Diagnosis, prevalence, pathophysiology and treatment optionsClinical Biochemistry, 2020
- The mortality increase in cardiac surgery patients associated with shrunken pore syndrome correlates with the eGFRcystatin C/eGFRcreatinine-ratioScandinavian Journal of Clinical and Laboratory Investigation, 2019
- The shrunken pore syndrome is associated with declined right ventricular systolic function in a heart failure population – the HARVEST studyScandinavian Journal of Clinical and Laboratory Investigation, 2016
- Ratio of cystatin C and creatinine-based estimates of the glomerular filtration rate predicts mortality in healthy seniors independent of kidney functionScandinavian Journal of Clinical and Laboratory Investigation, 2016
- Shrunken Pore Syndrome is associated with a sharp rise in mortality in patients undergoing elective coronary artery bypass graftingScandinavian Journal of Clinical and Laboratory Investigation, 2015
- The Preinterventional Cystatin-Creatinine-Ratio: A Prognostic Marker for Contrast Medium-Induced Acute Kidney Injury and Long-Term All-Cause MortalityNephron, 2015
- Reduction in glomerular pore size is not restricted to pregnant women. Evidence for a new syndrome: ‘Shrunken pore syndrome’Scandinavian Journal of Clinical and Laboratory Investigation, 2015
- Cystatin C versus Creatinine in Determining Risk Based on Kidney FunctionNew England Journal of Medicine, 2013
- Improved estimation of glomerular filtration rate (GFR) by comparison of eGFRcystatin Cand eGFRcreatinineScandinavian Journal of Clinical and Laboratory Investigation, 2011
- Cystatin C and the Risk of Death and Cardiovascular Events among Elderly PersonsNew England Journal of Medicine, 2005